Skip to Main Content

Paper Details

Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico.
Lipids Health Dis
5
2021
ALT, AST, NAFLD, Nonalcoholic fatty liver disease, PNPLA3, PNPLA3 genotype, TAG, TAGs, alanine, alanine aminotransferase, alcohol abuse, aspartate, aspartate aminotransferase, cholesterol esters, chronic liver disease, cirrhosis, diabetes, fatty acyl, lysophosphatidylcholines, metabolic syndrome, nonalcoholic fatty liver disease, obesity, patients, serum, sphingomyelins, triacylglycerols
Author NameAffiliation
Janet S Sinsheimeruniversity of california los angeles Department of Human Genetics and Computational Medicine
Janet S Sinsheimeruniversity of california los angeles Fielding School of Public Health
Janet S Sinsheimeruniversity of california los angeles Department of Human Genetics and Computational Medicine
Janet S Sinsheimeruniversity of california los angeles Fielding School of Public Health
Aldons J Lusisuniversity of california los angeles Department of Medicine, David Geffen School of Medicine
Aldons J Lusisuniversity of california los angeles Department of Microbiology, David Geffen School of Medicine
Folasade P MayFielding School of Public Health, University of California, Los Angeles (university of california los angeles)
Folasade P MayVA Greater Los Angeles Healthcare System
Folasade P Mayuniversity of california los angeles Department of Medicine, David Geffen School of Medicine
Folasade P Mayuniversity of california los angeles Center for Cancer Prevention and Control and university of california los angeles-Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center
Folasade P MayFielding School of Public Health, University of California, Los Angeles (university of california los angeles)
Folasade P Mayuniversity of california los angeles Center for Cancer Prevention and Control and university of california los angeles-Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center
Folasade P Mayuniversity of california los angeles Department of Medicine, David Geffen School of Medicine
Folasade P MayVA Greater Los Angeles Healthcare System
Roshan BastaniFielding School of Public Health, University of California, Los Angeles (university of california los angeles)
Roshan Bastaniuniversity of california los angeles Center for Cancer Prevention and Control and university of california los angeles-Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center
Roshan BastaniFielding School of Public Health, University of California, Los Angeles (university of california los angeles)
Roshan Bastaniuniversity of california los angeles Center for Cancer Prevention and Control and university of california los angeles-Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center
  • 1 - 18

Datasets